UICC III
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Optimization of Individualized Therapy for CRCs With Secondary RESISTance Towards Anti-EGFR Targeted Therapy Using an Avatar Model (NCT03263663) | PD Dr. med. Volker Heinemann | 2017-01-01 |
Track UICC III automatically
Every clearance here is in the API, with alerts when new ones post.